A quantitative lateral flow assay to detect complement activation in blood

Analytical Biochemistry

Volumn 477, Issue , 2015, Pages 78-85

  Schramm, Elizabeth C ^a,b   Staten, Nick R ^b   Zhang, Zhouning ^b   Bruce, Samuel S ^c   Kellner, Christopher ^c   Atkinson, John P ^a   Kyttaris, Vasileios C ^d   Tsokos, George C ^d   Petri, Michelle ^e   Sander Connolly, E ^c   Olson, Paul K ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Kypha Inc   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complement activation; iC3b biomarker; Intracerebral hemorrhage (ICH); Lateral flow assay; Lupus

Indexed keywords

BIOMARKERS; BLOOD;

COMPLEMENT ACTIVATIONS; HEALTHY INDIVIDUALS; INFLAMMATORY CONDITIONS; INNATE IMMUNE SYSTEMS; INTRACEREBRAL HEMORRHAGE (ICH); LATERAL FLOW ASSAY; LATERAL FLOW IMMUNOASSAY; LUPUS;

CHEMICAL ACTIVATION;

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C3;

ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; CROSS REACTION; DISEASE ACTIVITY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOLYSIS; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOASSAY; IN VITRO STUDY; LATERAL FLOW ASSAY; NEPHELOMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; QUANTITATIVE ASSAY; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; BLOOD ANALYSIS; IMMUNOLOGY; PROCEDURES; TIME FACTOR;

BLOOD CHEMICAL ANALYSIS; CEREBRAL HEMORRHAGE; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C3B; HUMANS; IMMUNOASSAY; LUPUS ERYTHEMATOSUS, SYSTEMIC; TIME FACTORS;

EID: 84961340409     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2015.01.024     Document Type: Article

References (42)

1. M.J. Walport Complement [first of two parts] N. Engl. J. Med. 344 2001 1058 1066
2. L.A. Trouw, and M.R. Daha Role of complement in innate immunity and host defense Immunol. Lett. 138 2011 35 37
3. P. Gasque Complement: a unique innate immune sensor for danger signals Mol. Immunol. 41 2004 1089 1098
4. B. Nilsson, and K. Nilsson Ekdahl The tick-over theory revisited: is C3 a contact-activated protein? Immunobiology 217 2012 1106 1110
5. M. Huber-Lang, J.V. Sarma, F.S. Zetoune, D. Rittirsch, T.A. Neff, and S.R. McGuire Generation of C5a in the absence of C3: a new complement activation pathway Nat. Med. 12 2006 682 687
6. U. Amara, M.A. Flierl, D. Rittirsch, A. Klos, H. Chen, and B. Acker Molecular intercommunication between the complement and coagulation systems J. Immunol. 185 2010 5628 5636
7. J.D. Lambris The multifunctional role of C3, the third component of complement Immunol. Today 9 1988 387 393
8. B.J.C. Janssen, A. Christodoulidou, A. McCarthy, J. Lambris, and P. Gros Structure of C3b reveals conformational changes that underlie complement activity Nature 444 2006 213 216
9. P. Gros, F.J. Milder, and B.J.C. Janssen Complement driven by conformational changes Nat. Rev. Immunol. 8 2008 48 58
10. M. Harboe, and T.E. Mollnes The alternative complement pathway revisited J. Cell. Mol. Med. 12 2008 1074 1084
11. M.K. Liszewski, C.J. Fang, and J.P. Atkinson Inhibiting complement activation on cells at the step of C3 cleavage Vaccine 26 Suppl. 8 2008 I22 I27
12. P.F. Zipfel, and C. Skerka Complement regulators and inhibitory proteins Nat. Rev. Immunol. 9 2009 729 740
13. V.M. Holers Complement and its receptors: new insights into human disease Annu. Rev. Immunol. 32 2014 433 459
14. B. Nilsson, K.N. Ekdahl, T.E. Mollnes, and J.D. Lambris The role of complement in biomaterial-induced inflammation Mol. Immunol. 44 2007 82 94
15. C.A. Alper, and F.S. Rosen Studies of the in vivo behavior of human C′3 in normal subjects and patients J. Clin. Invest. 46 1967 2021 2034
16. P. Warwicker, T.H. Goodship, R.L. Donne, Y. Pirson, A. Nicholls, and R.M. Ward Genetic studies into inherited and sporadic hemolytic uremic syndrome Kidney Int. 53 1998 836 844
17. L.H. Perrin, P.H. Lambert, and P.A. Miescher Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis J. Clin. Invest. 56 1975 165 176
18. R.E. Spitzer, E.H. Vallota, J. Forristal, E. Sudora, A. Stitzel, and N.C. Davis Serum C′3 lytic system in patients with glomerulonephritis Science 164 1969 436 437
19. M. Hiramatsu, J.E. Balow, and G.C. Tsokos Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis J. Immunol. 136 1986 4451 4455
20. G.S. Hageman, P.J. Luthert, N.H. Victor Chong, L.V. Johnson, D.H. Anderson, and R.F. Mullins An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration Prog. Retin. Eye Res. 20 2001 705 732
21. M. Griselli, J. Herbert, W.L. Hutchinson, K.M. Taylor, M. Sohail, and T. Krausz C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction J. Exp. Med. 190 1999 1733 1740
22. J.E. Salmon, C. Heuser, M. Triebwasser, M.K. Liszewski, D. Kavanagh, and L. Roumenina Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort PLoS Med. 8 2011 e1001013
23. E. Sim, A.B. Wood, L.M. Hsiung, and R.B. Sim Pattern of degradation of human complement fragment, C3b FEBS Lett. 132 1981 55 60
24. G.A. Posthuma-Trumpie, J. Korf, and A. van Amerongen Lateral flow (immuno)assay: its strengths, weaknesses, opportunities, and threats - a literature survey Anal. Bioanal. Chem. 393 2009 569 582
25. R.C. Wong, and H.Y. Tse Lateral Flow Immunoassay 2009 Springer New York
26. M. Garner, J. Lemon, P. Sing, irr: Various Coefficients of Interrater Reliability and Agreement (Version 0.83) [software], 2010. < http://CRAN.R-project.org/package=irr >.
27. S. Newell, J.C. Gorman, E. Bell, and J.P. Atkinson Hemolytic and antigenic measurements of complement: a comparison of serum and plasma samples in normal individuals and patients J. Lab. Clin. Med. 100 1982 437 444
28. T.E. Mollnes, P. Garred, and G. Bergseth Effect of time, temperature, and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation Clin. Exp. Immunol. 73 1988 484 488
29. G. Sturfelt, and L. Truedsson Complement and its breakdown products in SLE Rheumatology (Oxford) 44 2005 1227 1232
30. A.P. Manderson, M. Botto, and M.J. Walport The role of complement in the development of systemic lupus erythematosus Annu. Rev. Immunol. 22 2004 431 456
31. J. Leffler, A.A. Bengtsson, and A.M. Blom The complement system in systemic lupus erythematosus: an update Ann. Rheum. Dis. 73 2014 1601 1606
32. A.F. Ducruet, B.E. Zacharia, Z.L. Hickman, B.T. Grobelny, M.L. Yeh, and S.A. Sosunov The complement cascade as a therapeutic target in intracerebral hemorrhage Exp. Neurol. 219 2009 398 403
33. N. Negoro, M. Okamura, T. Takeda, S. Koda, K. Amatsu, and T. Inoue The clinical significance of iC3b neoantigen expression in plasma from patients with systemic lupus erythematosus Arthritis Rheum. 32 1989 1233 1242
34. J.M. Porcel, J. Ordi, A. Castro-Salomo, M. Vilardell, M.J. Rodrigo, and T. Gene The value of complement activation products in the assessment of systemic lupus erythematosus flares Clin. Immunol. Immunopathol. 74 1995 283 288
35. Y. Palarasah, K. Skjodt, J. Brandt, B. Teisner, C. Koch, and L. Vitved Generation of a C3c specific monoclonal antibody and assessment of C3c as a putative inflammatory marker derived from complement factor C3 J. Immunol. Methods 362 2010 142 150
36. J. Bronfenbrenner A biochemical study of the phenomena known as complement-splitting: first paper - splitting of the complement associated with globulin precipitation J. Exp. Med. 15 1912 598 624
37. C.B. Carpenter, S. Ruddy, I.H. Shehadeh, H.J. Müller-Eberhard, J.P. Merrill, and K.F. Austen Complement metabolism in man: hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary angioedema (HAE) J. Clin. Invest. 48 1969 1495 1505
38. L.D. Petz, D.J. Fink, E.A. Letsky, H.H. Fudenberg, and J. Müller-Eberhard In vivo metabolism of complement: I. Metabolism of the third component (C′3) in acquired hemolytic anemia J. Clin. Invest. 47 1969 2469 2484
39. V.A. Bokisch, and H.J. Müller-Eberhard Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase J. Clin. Invest. 49 1970 2427 2436
40. B. Nilsson, and K.N. Ekdahl Complement diagnostics: concepts, indications, and practical guidelines Clin. Dev. Immunol. 2012 2012 10.1155/2012/962702
41. J.A. Charlesworth, D.G. Williams, E. Sherington, P.J. Lachmann, and D.K. Peters Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia J. Clin. Invest. 53 1974 1578 1587
42. A.E. Bedwell, C.J. Elson, S.D. Carter, P.A. Dieppe, C.W. Hutton, and R. Czudek Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies Ann. Rheum. Dis. 46 1987 55 64